Literature DB >> 20538040

Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence.

Jia Yao1, Ryan T Hamilton, Enrique Cadenas, Roberta Diaz Brinton.   

Abstract

BACKGROUND: We have previously demonstrated that mitochondrial bioenergetic deficits precede Alzheimer's pathology in the female triple transgenic Alzheimer's (3xTgAD) mouse model. Herein, we sought to determine the impact of reproductive senescence on mitochondrial function in the normal non-transgenic (nonTg) and 3xTgAD female mouse model of AD.
METHODS: Both nonTg and 3xTgAD female mice at 3, 6, 9, and 12 months of age were sacrificed and mitochondrial bioenergetic profile as well as oxidative stress markers were analyzed.
RESULTS: In both nonTg and 3xTgAD mice, reproductive senescence paralleled a significant decline in PDH, and Complex IV cytochrome c oxidase activity and mitochondrial respiration. During the reproductive senescence transition, both nonTg and 3xTgAD mice exhibited greater individual variability in bioenergetic parameters suggestive of divergent bioenergetic phenotypes. Following transition through reproductive senescence, enzymes required for long-chain fatty acid (HADHA) and ketone body (SCOT) metabolism were significantly increased and variability in cytochrome c oxidase (Complex IV) collapsed to cluster at a approximately 40% decline in both the nonTg and 3xTgAD brain which was indicative of alternative fuel generation with concomitant decline in ATP generation.
CONCLUSIONS: These data indicate that reproductive senescence in the normal nonTg female brain parallels the shift to ketogenic/fatty acid substrate phenotype with concomitant decline in mitochondrial function and exacerbation of bioenergetic deficits in the 3xTgAD brain. GENERAL SIGNIFICANCE: These findings provide a plausible mechanism for increased life-time risk of AD in postmenopausal women and suggest an optimal window of opportunity to prevent or delay decline in bioenergetics during reproductive senescence.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538040      PMCID: PMC3200365          DOI: 10.1016/j.bbagen.2010.06.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

1.  Hormone therapy and the brain: déjà vu all over again?

Authors:  Kristine Yaffe
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

2.  Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.

Authors:  Eric M Blalock; James W Geddes; Kuey Chu Chen; Nada M Porter; William R Markesbery; Philip W Landfield
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

3.  Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

Authors:  Salvatore Oddo; Antonella Caccamo; Jason D Shepherd; M Paul Murphy; Todd E Golde; Rakez Kayed; Raju Metherate; Mark P Mattson; Yama Akbari; Frank M LaFerla
Journal:  Neuron       Date:  2003-07-31       Impact factor: 17.173

4.  Age at onset: important marker of genetic heterogeneity in Alzheimer's disease.

Authors:  R N Martins; J Hallmayer
Journal:  Pharmacogenomics J       Date:  2004       Impact factor: 3.550

5.  A sensitive spectrophotometric assay for pyruvate dehydrogenase and oxoglutarate dehydrogenase complexes.

Authors:  K Gohil; D A Jones
Journal:  Biosci Rep       Date:  1983-01       Impact factor: 3.840

Review 6.  Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise.

Authors:  J P Blass; R K Sheu; G E Gibson
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

Review 7.  Cerebral ketone body metabolism.

Authors:  A A M Morris
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

8.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.

Authors:  Eric M Reiman; Kewei Chen; Gene E Alexander; Richard J Caselli; Daniel Bandy; David Osborne; Ann M Saunders; John Hardy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

Review 9.  Ketone body synthesis in the brain: possible neuroprotective effects.

Authors:  Manuel Guzmán; Cristina Blázquez
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2004-03       Impact factor: 4.006

Review 10.  Pathways towards and away from Alzheimer's disease.

Authors:  Mark P Mattson
Journal:  Nature       Date:  2004-08-05       Impact factor: 49.962

View more
  57 in total

Review 1.  Estrogen neuroprotection and the critical period hypothesis.

Authors:  Erin Scott; Quan-guang Zhang; Ruimin Wang; Ratna Vadlamudi; Darrell Brann
Journal:  Front Neuroendocrinol       Date:  2011-11-04       Impact factor: 8.606

2.  Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid.

Authors:  Jia Yao; Ronald Irwin; Shuhua Chen; Ryan Hamilton; Enrique Cadenas; Roberta Diaz Brinton
Journal:  Neurobiol Aging       Date:  2011-04-22       Impact factor: 4.673

Review 3.  Minireview: translational animal models of human menopause: challenges and emerging opportunities.

Authors:  Roberta Diaz Brinton
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

Review 4.  Perimenopause as a neurological transition state.

Authors:  Roberta D Brinton; Jia Yao; Fei Yin; Wendy J Mack; Enrique Cadenas
Journal:  Nat Rev Endocrinol       Date:  2015-05-26       Impact factor: 43.330

5.  Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy.

Authors:  Yiwei Wang; Gerson Hernandez; Wendy J Mack; Lon S Schneider; Fei Yin; Roberta D Brinton
Journal:  Menopause       Date:  2020-01       Impact factor: 2.953

6.  The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity.

Authors:  Fei Yin; Jia Yao; Harsh Sancheti; Tao Feng; Roberto C Melcangi; Todd E Morgan; Caleb E Finch; Christian J Pike; Wendy J Mack; Enrique Cadenas; Roberta D Brinton
Journal:  Neurobiol Aging       Date:  2015-04-01       Impact factor: 4.673

Review 7.  Effects of polyphenols on brain ageing and Alzheimer's disease: focus on mitochondria.

Authors:  Sebastian Schaffer; Heike Asseburg; Sabine Kuntz; Walter E Muller; Gunter P Eckert
Journal:  Mol Neurobiol       Date:  2012-06-17       Impact factor: 5.590

Review 8.  Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.

Authors:  Jia Yao; Roberta Diaz Brinton
Journal:  Adv Pharmacol       Date:  2012

Review 9.  Premature menopause and risk of neurological disease: basic mechanisms and clinical implications.

Authors:  Erin L Scott; Quan-Guang Zhang; Ratna K Vadlamudi; Darrell W Brann
Journal:  Mol Cell Endocrinol       Date:  2014-01-22       Impact factor: 4.102

Review 10.  Hippocampal calcium dysregulation at the nexus of diabetes and brain aging.

Authors:  Olivier Thibault; Katie L Anderson; Chris DeMoll; Lawrence D Brewer; Philip W Landfield; Nada M Porter
Journal:  Eur J Pharmacol       Date:  2013-07-17       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.